Cerus (CERS) Cash from Investing Activities (2010 - 2026)
Cerus' (CERS) quarterly Cash from Investing Activities came in at $12.9 million in Q2 2026, up 1281.45% year-over-year from $931339.7 in Q2 2025, and up 30.49% quarter-over-quarter from $9.9 million in Q1 2026.
Analysis
Cerus (CERS) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Cerus has disclosed Cash from Investing Activities across 17 years of filings, most recently posting $12.9 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 1281.45% year-over-year to $12.9 million; the TTM figure through Jun 2026 stood at $18.8 million (up 496.86% YoY), while the FY2025 annual figure was -$6.2 million, up 24.17% from the prior year.
- Cash from Investing Activities came in at $12.9 million for Q2 2026 at Cerus, up from $9.9 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $12.9 million in Q2 2026 to a low of -$7.3 million in Q4 2024.
- Average Cash from Investing Activities over 5 years is $1.4 million, with a median of -$682000.0 recorded in 2023.
- The largest YoY upside for Cash from Investing Activities was 1851.64% in 2024 against a maximum downside of 405.15% in 2024.
- Over 5 years, Cash from Investing Activities stood at $7.4 million in 2022, then climbed by 11.28% to $8.2 million in 2023, then tumbled by 188.68% to -$7.3 million in 2024, then soared by 81.09% to -$1.4 million in 2025, then jumped by 1033.67% to $12.9 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $12.9 million in Q2 2026, $9.9 million in Q1 2026, and -$1.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn | 12.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.87 Mn |
| Mar 31, 2026 | 9.86 Mn |
| Dec 31, 2025 | -1.38 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Mar 31, 2025 | -1.19 Mn |
| Dec 31, 2024 | -7.29 Mn |
| Sep 30, 2024 | 4.82 Mn |
| Jun 30, 2024 | -7.11 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 8.22 Mn |
| Sep 30, 2023 | -275,000.00 |
| Jun 30, 2023 | 2.33 Mn |
| Mar 31, 2023 | -1.65 Mn |
| Dec 31, 2022 | 7.38 Mn |
| Sep 30, 2022 | -2.07 Mn |
| Jun 30, 2022 | -5.48 Mn |
| Mar 31, 2022 | 8.62 Mn |
| Dec 31, 2021 | -40.29 Mn |
| Sep 30, 2021 | 21.73 Mn |